Clinical Trials Explained
Research literacy for patients and families — from study phases and trial design to emerging therapies and what results really mean.
What 'First in Human' Actually Means: Decoding Phase One Research Trials
The phrase 'first in human' sounds alarming, but it does not mean untested. Here is what actually happens before and during Phase 1 trials: the years of preclinical science, FDA and IRB oversight, conservative starting doses, staggered cohorts, and the intensive real-time monitoring built around the uncertainty that remains.
Leqembi and Kisunla Are FDA-Approved. But How Do Patients Actually Get Them?
A practical guide to clinical eligibility, insurance steps, safety checks, and care delivery for new anti-amyloid therapies.
From Headline to Treatment: Why Medical Research Takes So Long
A promising headline is not the same thing as an available treatment. Understanding the difference can help patients and families hold onto hope without being misled by hype.
Phase 3 Trials: What They Mean and Why They Matter
Phase 3 clinical trials are the final large-scale test before a drug seeks FDA approval. Here's how they work, what the results mean, and how to read them critically.